Screener
AnaptysBio, Inc. ANAB Royalty Management Company — Other Nonoperating Income Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | Biopharma | Royalty Management | Total |
|---|---|---|---|
| (Loss) income from operations | (52,811) | 18,174 | (34,637) |
| Interest income | 2,328 | 325 | 2,653 |
| Non-cash interest expense | — | (20,859) | (20,859) |
| Other expense, net | (1) | — | (1) |
| Total other income (expense), net | 2,327 | (20,534) | (18,207) |
| Loss before income taxes | (50,484) | (2,360) | (52,844) |
| Provision for income taxes | — | (40) | (40) |
| Segment net loss | (50,484) | (2,400) | (52,884) |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s royalty management company — other nonoperating income expense?
- AnaptysBio, Inc. (ANAB) reported royalty management company — other nonoperating income expense of $0 in Q1 2026.
- How has AnaptysBio, Inc.'s royalty management company — other nonoperating income expense changed year-over-year?
- AnaptysBio, Inc.'s royalty management company — other nonoperating income expense decreased by 100.0% year-over-year, from $1.91M to $0.
- What does royalty management company — other nonoperating income expense mean?
- This metric includes gains or losses from activities outside the segment's primary business operations, such as asset disposals or foreign exchange fluctuations. It provides insight into the impact of peripheral financial events on the segment's overall performance.
Ask your AI about AnaptysBio, Inc.'s royalty management company — other nonoperating income expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude